The development of new pharmaceuticals relies heavily on the availability of specific and high-quality chemical intermediates. Methyl 5-allyl-3-methoxysalicylate, bearing the CAS number 85614-43-3, has emerged as a significant player in this domain, recognized for its utility as a pharmaceutical intermediate. Its chemical structure and reactivity profile make it an indispensable component in the synthesis of various active pharmaceutical ingredients (APIs).

One of the most notable uses of Methyl 5-allyl-3-methoxysalicylate is its role in the synthesis of Fallypride, a compound that has garnered attention in pharmacological research. Beyond this specific application, it also serves as a precursor for important molecular entities like enterobactin scaffolds and allylic amines. These diverse applications underscore its importance in advancing drug discovery and development pipelines.

For pharmaceutical researchers and manufacturers, sourcing Methyl 5-allyl-3-methoxysalicylate with guaranteed purity and consistency is paramount. The typical specification of 98% purity ensures that the compound will perform reliably in complex multi-step syntheses, minimizing the risk of side reactions or impure final products. Its physical state as a white to pale yellow crystalline powder, with a defined melting point, further aids in quality assessment.

When considering the purchase of this essential pharmaceutical intermediate, prospective buyers should carefully evaluate potential suppliers. Factors such as production capacity, adherence to quality standards (like ISO certifications), and the ability to provide comprehensive documentation are crucial. Understanding the methyl 5-allyl-3-methoxysalicylate price in relation to purity and quantity is also a key consideration for cost-effective API development.

The chemical properties of Methyl 5-allyl-3-methoxysalicylate, including its molecular formula (C12H14O4) and molecular weight (222.24 g/mol), provide chemists with the necessary data for reaction planning. Its integration into synthetic schemes often involves transformations of its allyl group or ester functionality, making it a versatile intermediate for creating a range of medicinal compounds.

In conclusion, Methyl 5-allyl-3-methoxysalicylate plays a vital role in the pharmaceutical industry as a key intermediate. Its ability to facilitate the synthesis of complex APIs highlights its value. For organizations involved in drug development, securing a dependable supply of this methyl 5-allyl-3-methoxysalicylate is a strategic imperative for success.